Adaptimmune Therapeutics Plc (ADAP) Insider Trading

Total insider buys:
  • $80,274,368.40
Total insider sells:
  • $25,072,315.08
Most recent insider trade:
  • Sept. 1, 2023
Most active insider trader:
  • Adrian Rawcliffe
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 13, 2020Director300,000$4.67Sell$1,401,000.00
Jan. 6, 2020CEO5,900$1.20Sell$7,080.00
Jan. 6, 2020Insider1,148$1.20Sell$1,377.60
Jan. 6, 2020COO3,731$1.20Sell$4,477.20
Aug. 6, 2019Insider11,043$2.06Sell$22,748.58
Jan. 14, 2019CFO3,084$5.37Sell$16,561.08
Jan. 14, 2019CTO1,514$5.37Sell$8,130.18
Jan. 14, 2019Insider3,028$5.37Sell$16,260.36
Jan. 14, 2019COO2,271$5.37Sell$12,195.27
Dec. 17, 2018Director47,280$0.84Buy$39,715.20
Oct. 1, 2018Insider25,000$13.79Sell$344,750.00
Sept. 7, 2018Director12,000,000$1.67Buy$20,040,000.00
Sept. 7, 2018Major Shareholder3,000,000$1.67Buy$5,010,000.00
Aug. 29, 2018Insider25,000$10.25Sell$256,250.00
June 6, 2018Director18,700$13.56Sell$253,572.00
June 4, 2018Director17,100$13.57Sell$232,047.00
June 1, 2018Director171,000$13.51Sell$2,310,210.00
May 30, 2018Director121,000$13.52Sell$1,635,920.00
May 14, 2018Director10,300$13.50Sell$139,050.00
March 29, 2018Director1,048,067$11.50Sell$12,052,770.50
March 27, 2018Major Shareholder6,571,164$1.92Buy$12,616,634.88
March 26, 2018Director571,164$1.90Buy$1,085,211.60
March 23, 2018Major Shareholder1,268,508$1.91Buy$2,422,850.28
March 22, 2018Director869,574$1.90Buy$1,652,190.60
March 21, 2018Major Shareholder104,844$1.81Buy$189,767.64
March 20, 2018CFO600,000$1.71Sell$1,026,000.00
March 27, 2017Director1,190,476$4.20Buy$4,999,999.20
March 27, 2017Major Shareholder12,870,000$0.70Buy$9,009,000.00
May 24, 2016Director1,712,400$10.42Buy$17,843,208.00
May 19, 2016Director15,000$1.56Buy$23,400.00
May 18, 2016Director45,000$1.53Buy$68,850.00
First«2 of 2»Last
  • Insiders are both buying and selling Adaptimmune Therapeutics Plc stock.

  • The insider traders at Adaptimmune Therapeutics Plc are: Adrian Rawcliffe, John Lunger, William C. Bertrand, Jr., William C Bertrand Jr, Orbimed Advisors Llc, Enterprise Associates 14 New, Peter A Thompson, Gavin Wood, Gwendolyn Knowlt Binder-Scholl, Elliot Norry, James Noble, Charles Elliott Sigal, David M Mott, Lawrence M. Alleva, Rafael Amado, Ali Behbahani, Garry E Menzel, Peter W Sonsini, Ravi Viswanathan, and Cintia Piccina

  • The most active insider trader at Adaptimmune Therapeutics Plc is Adrian Rawcliffe with 21 trades.

  • Orbimed Advisors Llc has sold the most Adaptimmune Therapeutics Plc stock with a total value of $14,870,124.50.

  • Ali Behbahani has bought the most Adaptimmune Therapeutics Plc stock with a total value of $40,080,000.00.

  • The most recent insider trade for Adaptimmune Therapeutics Plc was on Sept. 1, 2023.

  • The single biggest insider buy for Adaptimmune Therapeutics Plc was from Ali Behbahani with a total value of $20,040,000.00 on Sept. 7, 2018.

  • The single biggest insider sell for Adaptimmune Therapeutics Plc was from Orbimed Advisors Llc with a total value of $12,052,770.50 on March 29, 2018.